Leptin acts on its receptor (ObR) in the hypothalamus to inhibit food intake and energy expenditure. Leptin and ObR are also expressed in the gastrointestinal tract; however, the physiological significance of leptin signaling in the gut remains uncertain. Suppressor of cytokine signaling 3 (SOCS3) is a key negative feedback regulator of ObR-mediated signaling in the hypothalamus. We now show that gastrointestinal epithelial cell-specific SOCS3 conditional knockout (T3b-SOCS3 cKO) mice developed gastric tumors by enhancing leptin production and the ObRb/signal transducer and activator of transcription 3 (STAT3) signaling pathway. All T3b-SOCS3 cKO mice developed tumors in the stomach but not in the bowels by 2 months of age, even though the SOCS3 deletion occurred in both the epithelium of stomach and bowels. The tumors developed in the absence of the inflammatory response and all cKO mice died within 6 months. These tumors displayed pathology and molecular alterations, such as an increase in MUC2 (Mucin 2, oligomeric mucus/gel-forming) and TFF3 (trefoil factor 3), resembling human intestinal-type gastric tumors. Administration of antileptin antibody to T3b-SOCS3 cKO mice reduced hyperplasia of gastric mucosa, which is the step of the initiation of gastric tumor. These data suggest that SOCS3 is an antigastric tumor gene that suppresses leptin overexpression and ObRb/STAT3 hyperactivation, supporting the hypothesis that the leptin/ObRb/STAT3 axis accelerates tumorigenesis and that it may represent a new therapeutic target for the treatment of gastric cancer.
INTRODUCTION
Since leptin was discovered in adipose tissue, 1 this hormone has been demonstrated to be pivotal role in many biological functions such as regulation of food intake and energy expenditure. 2 Extensive research has revealed that leptin exerts a pleiotropic effect on hematopoiesis, 3 angiogenesis 4 and innate and adaptive immunity. 5 Leptin and its receptor (ObR) are also expressed in various tissues including the stomach and bowels. 6, 7 Two main roles for gastric leptin have been proposed. The first is that leptin is constitutively produced in the stomach, and the gastric leptin is secreted in the lumen and enters the intestine to directly act on the intestinal epithelium to enhance nutrient absorption. 8, 9 The second is that leptin is involved in the regulation of gut physiology by affecting angiogenesis, antiapoptosis and cell proliferation. 4, 10 However, the physiological function of the leptin signaling pathway and the mechanisms regulating leptin/ ObR in the gastrointestinal mucosa have not been clarified.
ObR belongs to the class I cytokine receptor family, and it utilizes a signaling pathway similar to that used by gp130. 11, 12 Of the six isoforms of ObR, only ObRb, the long form of ObR, can transduce Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling. ObRb is constitutively expressed in normal gastric and intestinal epithelium. 8, 13, 14 After leptin binds to ObRb, ObRb-associated JAK2 is activated, and tyrosine is phosphorylated at the cytoplasmic domain of the ObRb, inducing STAT3 activation. 11, 12 Suppressor of cytokine signaling 3 (SOCS3) is an inducible suppressor of leptin signaling through the inhibition of JAK2 by binding to ObRb. 15, 16 Forced SOCS3 expression inhibits leptin-induced tyrosine phosphorylation of JAK2 in vitro. 17 Expression of SOCS3 mRNA is specifically induced through the binding of leptin and ObRb in the hypothalamus, 18 and neuron-specific deletion in Socs3 mice increases leptin sensitivity through STAT3 activation in the hypothalamus, 19 indicating that SOCS3 is an important negative feedback regulator of leptin signaling mediated by the JAK2/ObRb/STAT3 pathway both in vitro and in vivo.
Recently, accumulating evidence has indicated the significance of the leptin/SOCS3 signaling cascade in the gastrointestinal tract based on the relationship between leptin signaling, cancer and inflammation. Indeed, it has been reported that abundant leptin production by tumors cells is correlated with the progression of gastric 14, 20 and colorectal cancer. 21 Very recently, it has been demonstrated that ObR is strongly expressed in tumor-infiltrating stem cells including embryonic stem cells, 22 suggesting that leptin may be critically involved in carcinogenesis. Leptin and ObR are highly expressed in gastric cancer cells. 14 In the bowel, leptin and ObR expression is increased in the inflamed colon in humans and mice. 23 In ulcerative colitis and in its related colon cancer patients, phosphorylated STAT3 (p-STAT3) is highly occurred and methylation of SOCS3 gene is detected in the mucosa-associated cancer lesion. 24 Nonetheless, villin promoter-mediated intestinal epithelial cell (EC)-specific SOCS3-deficient mice did not spontaneously show a discernible enteric phenotype and only inflammation-related tumor formation is detected after administration of dextran sodium sulfate or azoxymethane. 25 Thus, it is necessary to explore the differential role of the leptin/SOCS3 signaling cascade in gastrointestinal pathophysiology in the stomach and bowels. Therefore, we generated a mouse model of gastrointestinal EC-specific SOCS3 conditional knockout (cKO) mice.
In this study, we show that the EC-SOCS3 cKO mice with SOCS3 deficiency in both the stomach and bowels spontaneously develop gastric tumors mediated through the acceleration of leptin/ObRb signaling without induction of an inflammation. The cKO mice are useful in examining a potential gut function and tumorigenesis link between SOCS3 and leptin physiology. Therefore, SOCS3 regulation of the leptin/ObRb/STAT3 signaling axis is an important checkpoint during gastric tumorigenesis and is a promising therapeutic target for gastric tumors.
RESULTS

Generation of gastrointestinal EC-specific SOCS3 knockout mice
To evaluate the role of leptin signaling in gastrointestinal epithelium, we established mice with a SOCS3 gene deletion in the gastrointestinal ECs. First, we generated mice in which Cre recombinase was specifically expressed in gastrointestinal ECs under the T3b promoter (T3b-Cre Tg mice; Figure 1a) , and then crossed them with SOCS3 flox/flox mice. Cre mRNA was specifically expressed in the stomach and the small and large bowels of the T3b-Cre Tg mice (Figure 1b) . Deletion of Socs3 was demonstrated in the ECs of the stomach and small and large bowels of the T3b-SOCS3 cKO mice (Figure 1c ). SOCS3 induction was detected in the leukemia inhibitory factor-stimulated gastrointestinal ECs of the control mice but not in the cKO mice (Figure 1d ). It is well documented that phosphorylation of STAT3 is essential for leptin signaling through ObRb. 26 We observed sustained STAT3 phosphorylation in the gastric mucosa of leptin-treated cKO mice, whereas control mice showed transient activation ( Figure 1e ). These results indicated the efficient and functional Cre-mediated specific deletion of the SOCS3 gene in the gastrointestinal ECs of T3b-SOCS3 cKO mice. SOCS3 deletion in the gastrointestinal ECs causes spontaneous gastric tumors No T3b-SOCS3 cKO mice survived beyond 6 months (Supplementary Figure S1a) . The T3b-SOCS3 cKO mice had significantly reduced body weight and food intake compared with littermate control mice ( Supplementary Figures S1b and c) . All cKO mice exhibited an enlarged stomach with multiple tumors until 8 weeks of age; these tumors were histologically adenocarcinoma with a higher Ki67-positive proliferating cell frequency (Figure 2a ). No such lesions were observed in the small and large bowels (Supplementary Figure S2) , although Socs3 was deleted not only in the stomach but also in the bowels (Figure 1c) . Thus, our analysis on pathogenesis in the cKO mice focused on the stomach. Histological analysis revealed that in addition to hyperplasia, adenomatous gastric lesions appeared by 3 weeks of age and were developed by 8 weeks of age in the cKO mice (Figure 2b ). The mucosa was entirely replaced by atypical glands showing an irregular fused structure, which was consistent with an adenocarcinoma (Figure 2b ). We found age-related progression of tumorous lesions (Figure 2c Figures S3a and b) , and the nuclear accumulation of b-catenin were observed in carcinomatous epithelium of the cKO mice but not in that of control mice (Supplementary Figure  S3c) . Suppression of E-cadherin expression is correlated with tumor progression in gastric and other cancers. [27] [28] [29] A decrease in E-cadherin and an increase in Snail, an E-cadherin repressor, were observed (Supplementary Figures S3c) . We also confirmed that gastric ECs separated from the cKO mice, which could produce acidic mucin, proliferated spontaneously in an in vitro culture system (Supplementary Figure S4) , whereas those from control mice did not. These results indicated that SOCS3 deletion in the gastric mucosa results in acceleration of EC proliferation with alteration of epithelial integrity at a young age, and suggest the eventual development of inflammation-independent spontaneous gastric tumors.
Leptin signaling is enhanced in the gastric mucosa of SOCS3-deficient mice We examined the expression of leptin, p-STAT3 and p-ObRb in the stomachs of T3b-SOCS3 cKO mice. Abundant leptin was detected at the gastric epithelium of the 3-week-old cKO mice, and this expression level was augmented at 8 weeks of age (Figures 3a and  d) . Importantly, leptin mRNA expression was increased in SOCS3-deleted gastric ECs of 3-week-old cKO mice ( Figure 3e ). P-ObRb was detected in 3-week-old cKO mice, and its expression level was significantly higher and had a wider distribution in the gastric mucosa in parallel to leptin expression compared with that in the control mice (Figures 3b and d ). p-STAT3 was also detected in the EC nucleus in cKO mice at 3 weeks of age and then diffusely expressed in the tubular to the glandular epithelium at 8 weeks of age (Figures 3c and d) . In contrast, the frequency of p-STAT3-positive cells was lower in the small and large intestines of 8-week-old cKO mice (Supplementary Figure S5) . These results indicate that SOCS3 deletion in ECs resulted in a high level of leptin production and acceleration of leptin signaling.
Changing characterization of gastric mucosa to intestinal type resulting from SOCS3 deletion in the gastric mucosa As gastric epithelial integrity was changed in cKO mice at 3 weeks of age (Figure 2 ), we examined stomach-specific gene in the cKO mice. The expression level of atp4a, atp4b, gast, gif and ghrel, which encoded to H þ K þ -ATPase, gastrin, gastric intrinsic factor and ghrelin in the stomach, was significantly decreased in SOCS3-deleted gastric ECs at 3 weeks of age (Figure 4a ). Especially, in gastric tumors of the cKO mice, H þ K þ -ATPase expression, a marker of parietal cells, was also dramatically decreased at the protein level (Figure 4b ). The gastric epithelia in cKO mice preferentially produced Alcian blue-positive acidic mucin (Figure 4c ), indicating overt acidification of mucins in human gastric adenocarcinoma.
30 MUC2 (Mucin 2, oligomeric mucus/gelforming), the intestinal-type mucin, was ectopically expressed in cKO mice, whereas it was not expressed in the gastric mucosa of control mice, indicating that gastric mucin is altered to the intestinal type, similar to most human gastric carcinomas 31 ( Figure 4c ). Trefoil factor 3 (TFF3), a peptide coexpressed with MUC2, was also expressed in the cKO mice (Figure 4c ), indicating that intestinal metaplasia-like alterations occur in the cKO mice. Supporting this notion, mRNA expression of muc2 and tff3 was increased, whereas that of gastric-type mucins, muc1, muc5ac and muc6, was decreased in the stomach of 3-week-old cKO mice (Figure 4a ). The mRNA level of cdx2, a marker of intestinal EC differentiation, 32 was increased, whereas that of barx1, a marker of gastric EC differentiation, 33 was decreased (Figure 4a ). These results indicate that SOCS3-deleted gastric mucosa altered the direction of epithelial differentiation from the stomach to the intestinal type.
Gastric tumor in SOCS3-deficient mice is not associated with inflammation Many solid tumorigeneses are considered to be triggered by chronic inflammation.
34 CD45-positive infiltrating cells were detected after but not before tumor formation in the cKO mice (Figure 2d ), suggesting that inflammation is not required for SOCS3-loss-derived tumorigenesis. To confirm this, we examined the time course of inflammation in the cKO mice. The expression of leptin peaked at 8 weeks in cKO mice and then decreased at 15 weeks, when interleukin (IL)-6 and IL-11 expression increased (Figure 5a ). ObR are expressed in a variety cells other than ECs, including T cells, myeloid cells and monocytes/macrophages. 5 There was no change in the CD3 þ cell frequency in the gastric mucosa between 8-week-old and 15-week-old cKO and control and p-STAT3 accelerate their expansion. 36 In the cKO mice, Gr-1 þ CD11b þ cells did not increase by 15 weeks of age, and F4/80 þ CD11b þ conventional macrophages showed no difference between cKO and control mice (Figure 5b ). This result is consistent to observe little CD45-positive infiltrated cells in young cKO mice (Figure 2d ). These results show that gastric tumorigenesis was triggered by intrinsic signaling of ECs but not by inflammatory responses in the cKO mice.
Sp1/STAT3 complex is augmented in SOCS3-deficient ECs We showed that upregulation of leptin signaling due to loss of SOCS3 resulted in development of gastric tumors. The mouse leptin gene does not contain a consensus sequence for STAT3 but it does contain one for Sp1, 37 which is a transcription activator that assembles to STAT3 to translocate into nuclei and regulates target gene promoter activities. 38 Thus, we examined coprecipitation of p-STAT3 and Sp1 in SOCS3-deficient gastric epithelium. A large amount of Sp1 was expressed and coprecipitated with p-STAT3 in SOCS3-deficient gastric epithelium (Figure 6a) . Immunohistochemical analysis revealed a high frequency of p-STAT3 and Sp1 colocalization (Figure 6b ). Sp1po-sitive cells also co-localized with leptin ( Figure 6c ). These results suggest that p-STAT3 could act on Sp1 to upregulate leptin expression.
Blockade of leptin ameliorated gastric lesions To clarify the significance of leptin in gastric tumorigenesis in the T3b-SOCS3 cKO mice, we examined the effects of anti-leptin antibody (Ab) on the development of gastric tumors in the cKO mice. Anti-leptin Ab treatment for 4 weeks significantly reduced STAT3 hyperactivation, hyperplastic morphology and Alcian bluepositive acidic mucin at the fundic segment of the stomach (Figure 7a ). As shown in Figure 7b , anti-leptin Ab treatment significantly reduced the histological score in 5-week-old cKO mice (Figure 7b ). The data suggest that leptin plays an important role in the early stage of tumorigenesis in the gastric epithelium of the cKO mice and that blockade of leptin/ObR axis might be a prophylactic strategy against gastric tumor development.
DISCUSSION
This work first provided the murine model that enhanced leptin/ ObR signaling causes gastric tumors. We found that SOCS3-deficient EC in the stomach induces the enhanced and continuous activation of leptin/ObR signaling via STAT3, initiates hyperproliferation without induction of inflammation, mimics intestinal metaplasia and eventually promotes adenocarcinoma formation. These results made a great progress in understanding the role of leptin signaling in gastric malignancy from previous reports, in which upregulation of leptin and ObR in the gastric mucosa of gastric cancer patients has been shown. 14, 39, 40 The maintenance of gastric mucosal integrity is likely dependent on a mechanism that is different from that in the bowels. Despite SOCS3 deletion from all ECs of the gastrointestinal tissues in the T3b-SOCS3 cKO mice, tumorigenesis was restricted to the stomach, suggesting that tissue specificity for leptin signaling exists. ObR is expressed in both the stomach and bowels, whereas leptin is constitutively produced by stomach but not by bowels. 6, 41 Both leptin and ObR are constitutively expressed by chief cells and parietal cells, which constitute the majority of the fundic cell populations in the stomach. 6, 7, 42 Therefore, it is thought that more potent ObRb-mediated signaling constitutively activates STAT3 in the gastric fundus compared with the bowels in control mice (Figure 3c and Supplementary Figure S5 ). In the absence of SOCS3, the constitutive STAT3 activation in the Intestinal metaplasia is considered to be a risk factor for developing gastric adenocarcinoma. Leptin and ObRb were reported to be frequently coexpressed in intestinal-type gastric adenocarcinoma.
14, 40 We indicated that high leptin levels in SOCS3-deficient gastric epithelium upregulated an intestinalspecific gene, cdx2, and downregulated expression of barx1, which is essential in gastric EC differentiation (Figure 4a) . The cdx2-null mutation results in development of the gastric phenotype in the midgut endoderm and, conversely, forced expression of cdx2 in the stomach induces the endoderm to differentiate into intestinal-type mucosa; 43 these results suggest that cross-talk between cdx2 and barx1 induce appropriate cell differentiation in the gut. As leptin enhances cdx2 transcription factors, 44 leptin is considered to regulate barx1 expression indirectly. Furthermore, it has been recently reported that tumor-initiating stem cells potently express ObR, resulting in tumor progression mediated through STAT3 activation and induction of pluripotency-associated transcription factors, such as oct4 and sox2. 22 This evidence implicates that leptin actively affects tumor formation and supports to cell proliferation and pluripotency for tumorigenesis. These results suggested that overexpression of leptin likely induces intestinal metaplasia in the gastric epithelium. Localization of leptin-producing cells coincides with that of adenomatous lesions in the fundic mucosa during the early stage of tumorigenesis in T3b-SOCS3 cKO mice. Increased leptin and activated ObRb resulted in increased p-STAT3 in the stomachs of cKO mice (Figure 3) . Considering that STAT3 activation is also observed in the bowels of villin-SOCS3 cKO mice and that little spontaneous phenotype was observed, 25 the stomach is likely one of the tissues most affected by leptin autocrine signaling. 14 A causal link between chronic inflammation induced by STAT3 activation and carcinogenesis has long been proposed, and considerable insight into the underlying molecular mechanisms has been recently shown. Gp130 and ObRb have a very similar structure; SOCS3 inhibits JAK2-dependent signaling in both receptors. Gp130 757F mice with mutated gp130 that cannot bind to SOCS3 showed abrogation of SHP-2-ERK, and enhancement of the STAT3 pathway and inflammation-associated gastric adenocarcinomas with a reduction in leptin expression in the gastric mucosa. 45 A possible explanation is that gp130 757F mice can enable SOCS3 induction, which can bind to JAK2 and Tyr1138 of ObRb, a STAT3-binding site, resulting in a decrease in leptin expression. 46 In contrast, because of the lack of SOCS3 in the T3b-SOCS3 cKO mice, neither JAK2 phosphorylation nor Tyr phosphorylated STAT3-binding sites on both gp130 and ObRb are blocked. Thus, the effect of SOCS3 deletion is more broad and stronger than gp130 757F mutation. In this gastric molecular environment, T3b-SOCS3 cKO mice may develop pathogenicity in the epithelium and tumorigenesis in the stomach at an early stage of life and show more severe phenotype than gp130 757F mice.
Recently, ChIP-chip (chromatin immunoprecipitation with microarray technology) microarray analysis of the STAT3-binding target revealed that STAT3 also binds to a promoter in the leptin gene. 47 It has also been reported that STAT3 can bind to the leptin promoter region using HT-29, which are human colon cancer cells, 48 suggesting that leptin is a direct downstream target of STAT3 and the autocrine leptin loop could exist. In contrast, the consensus Sp1 and C/EBP motifs are identified in the leptin promoter, 37 and activated STAT3 assembles with Sp1 to bind the transcriptionally active C/EBP motif. 38 As we showed association and colocalization of p-STAT3 with Sp1 ( Figure 6 ), STAT3 may indirectly activate the leptin promoter by interacting with Sp1. The early tumorigenesis shown in T3b-SOCS3 cKO mice may be because of STAT3 hyperactivation, which affects leptin gene transcription and forms a positive feedback loop of leptin signaling.
We have shown that T3b-SOCS3 cKO mice treated with antileptin Ab from 1 to 4 weeks of age had significantly reduced gastric epithelial hyperplasia at fundic segment compared with controls ( Figure 7 ). Because this anti-leptin Ab-induced reduction of epithelial hyperplasia was not observed when T3b-SOCS3 cKO mice were treated after 5 weeks of age (data not shown), and because the cKO mice exhibited hyperplasia of gastric mucosa a few weeks after birth, leptin signaling may be involved in the early phase of gastric tumorigenesis.
In summary, we established a mouse model with an enhanced leptin/ObRb/STAT3 signaling pathway in the gastrointestinal tract by deleting SOCS3 in the tissues, and found that mice developed gastric tumors in the early stage of life. The lepin/ObRb/STAT3 axis may represent a new target for the prophylaxis of gastric tumors.
MATERIALS AND METHODS
Generation of T3b-Cre transgenic (Tg) mice
To generate gastrointestinal Cre Tg mice, we used the T3b-promoter system. 49 The T3b-IL-12 region was cut out of the T3b-IL-12 vector 49 (a gift from Dr Jun-ichi Miyazaki, Osaka University, Japan) by KpnI/XhoI digestion and subcloned into the KpnI/XhoI site of pcDNA3 (Invitrogen, Carlsbad, CA, USA). The Cre-coding region was subcloned into the EcoRI site of the T3b-IL-12 in pcDNA3. The T3b-Cre fragment was isolated by KpnI/XhoI digestion and injected into the pronuclei of BDF1 fertilized eggs to generate T3b-Cre Tg mice. To screen founder transgenic mice, tail DNA was genotyped using PCR under the following conditions: a 5 0 -specific primer (primer 'p1' depicted in Figure 1a ) of the T3b promoter (5 0 -CCCGGAAGTGGCTGT-CAGGG-3 0 ) and a 3 0 -specific primer (primer 'p2' depicted in Figure 1a ) of the Cre-coding region (5 0 -CGCCCACGACCGGCAAACGGA-3 0 ). Socs3 flox/flox mice have been previously described. 50 Detection of the endogenous, floxed and disrupted Socs3 alleles using PCR has been also described. T3b-Cre Tg mice were crossed with Socs3 flox/flox mice to generate offspring carrying the Cre gene and the heterozygous floxed Socs3 gene (T3b-Cre Socs3 flox/ þ ). These mice were further mated with Socs3 flox/flox mice to generate T3b-Cre Socs3 flox/flox mice. All animals used in this study were generated by crossing T3b-Cre Socs3 flox/flox cKO mice and Socs3 flox/flox mice and we used Socs3 flox/flox littermates as experimental controls. Animal care and all experiments were conducted in accordance with the institutional guidelines of the University of the Ryukyus, National Institute for Physiological Sciences (NIPS) and National Center for Global Health and Medicine (NCGM).
Treatment of recombinant leptin
To detect leptin-induced STAT3 activation in the gastric mucosa, 5-weekold cKO and control mice were intravenously administered with 5 mg of leptin (Wako, Osaka, Japan). Stomach lysates were prepared for western blot analysis at timed intervals after administration.
Antibodies
The Abs used in western blotting and immunohistochemical analysis are described in Supplementary Information.
Immunohistochemical analysis
Paraffin-embedded sections of 10% formalin-fixed tissues were stained with hematoxylin and eosin or with periodic acid-Schiff and Alcian blue. For antigen retrieval, deparaffinized and rehydrated specimens were microwaved (for staining of Ki-67, Bcl-xL, E-cadherin, Snail, p-ObR and CD45) in a Retrieval kit (BD Biosciences, San Jose, CA, USA) or 30 mg/ml proteinase K-treatment (for p-STAT3, b-catenin and leptin). Endogenous peroxidase activity was blocked by 3% hydrogen peroxide in methanol. The slides were then incubated with the primary Ab at 4 1C overnight. Subsequently, these were incubated at room temperature with a biotinylated secondary Ab and streptavidin labeled with peroxidase and 3,3 0 -diaminobenzidine, followed by counterstaining with hematoxylin. For immunofluorescent staining, the slides that reacted with the primary Abs were stained with Alexa 488-conjugated rabbit or mouse IgG Ab or Alexa 556-conjugated goat IgG Ab and mounted by ProLong Gold antifade reagent with 4,6-diamidino-2-phenylindole (Invitrogen) for detection by fluorescence microscope (Olympus, Tokyo Japan).
Western blot analysis
Lysates were prepared from tissues and cells and analyzed by western blotting according to a published method. 51 Quantitative analysis of western blotting was performed using ImageJ software (http:// rsb.info.nih.gov/ij/index.html).
Immunoprecipitation
Lysates from the gastric mucosa were precipitated using anti-p-STAT3, anti-Sp1 Ab (Santa Cruz, Santa Cruz, CA, USA) or control IgG. The precipitates were immunoblotted using anti-p-STAT3 and anti-Sp1 Ab. Immunocomplexes were detected using horseradish peroxidase-conjugated secondary Abs and enhanced chemiluminescence.
Histopathologic analysis
Stomach sections from the cKO and control mice were stained with hematoxylin and eosin. Assessment of mucosal alteration in the stomach was based on a summation of scores for hyperplasia (0, no substantial alteration; 1, low; 2, moderate; and 3, high), dysplasia (4, low; 5, moderate; and 6, high) and carcinoma (7) and cell proliferation (0, no substantial alteration; 1, low; 2, moderate; and 3, high) by two observers who were blinded to treatment groups. In an experiment with antibody treatment, assessment of mucosal alteration in the stomach was based on a summation of scores for hyperplasia (0, no substantial alteration; 1, low; 2, moderate; and 3, high) and Alcian blue stain (0, normal; 4, focal; and 5, diffuse).
Antibody treatment
Intraperitoneal treatment with 100 mg anti-leptin Ab started in cKO mice at 1 week of age just after weaning and continued to the age of 4 weeks. At 3 days after the final Ab treatment, mice were killed, serum samples were collected and tissues were fixed in 10% neutral formalin to prepare paraffin-embedded sections for pathological and immunohistochemical analyses.
Real-time PCR
Total RNA was extracted from gastric ECs in the cKO and control mice using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Real-time PCR was carried out by using the specific primer sets shown in Supplementary Table  S1 and mRNA expression was assessed as described previously. 52 Quantitative analysis of gastric lesions For microscopic measurement, hematoxylin and eosin-stained stomachs were photographed using a microscope (Olympus) and subsequently quantitative analysis was performed using ImageJ software.
Flow cytometric (FACS) analysis
Cells were stained as described previously. 53 The monoclonal Abs used in this study are described in Supplementary Information. Flow cytometry analysis was performed using a FACSCalibur flow cytometer (BD Biosciences).
Statistics
The Student's t -test was used to determine significant differences. A P-value of o0.05 was considered significant.
